Figure 2D shows that patients with recurrent breast cancer had significantly higher levels of serum CA15.3 compared with patients that remained recurrence-free for 5 years (P=0.0164). CEA measurements did not distinguish NSR from REC samples (Figure 2E). Here, CEACAM5 is linked to breast cancer.